A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus.

Bang, Sun-Hwi; Yoon, Jeung-Won; Cho, Chong-Kwan; Shin, Ji-Eun; Lee, Yeon-Weol; Yoo, Hwa-Seung

Bang, Sun-Hwi; Yoon, Jeung-Won; Cho, Chong-Kwan; Shin, Ji-Eun; Lee, Yeon-Weol; Yoo, Hwa-Seung.

Afiliação

Bang SH; East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University, Daejeon, Korea.
Yoon JW; East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University, Daejeon, Korea.
Cho CK; East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University, Daejeon, Korea.
Shin JE; Department of Statistics, Chungnam National University, Daejeon, Korea.
Lee YW; East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University, Daejeon, Korea.
Yoo HS; East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University, Daejeon, Korea.

J Pharmacopuncture ; 15(2): 31-5, 2012 Jun.

Article em En | MEDLINE | ID: mdl-25780640

Palavras-chave

HangAm-Plus(HAP); antitumor; cancer treatments; non-small-cell lung cancer; overall survival; progression-free survival

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Pharmacopuncture Ano de publicação: 2012 Tipo de documento: Article